Hmdb loader
Survey
Record Information
Version5.0
StatusExpected but not Quantified
Creation Date2012-09-06 15:00:12 UTC
Update Date2021-09-14 15:16:19 UTC
HMDB IDHMDB0013848
Secondary Accession Numbers
  • HMDB13848
Metabolite Identification
Common Name4-Hydroxyvalsartan
Description4-Hydroxyvalsartan belongs to the class of organic compounds known as valine and derivatives. Valine and derivatives are compounds containing valine or a derivative thereof resulting from reaction of valine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. 4-Hydroxyvalsartan is a metabolite of Valsartan. 4-Hydroxyvalsartan is an extremely weak basic (essentially neutral) compound (based on its pKa). A carbon atom of the biphenyl moiety is boned to a carbon or the nitrogen atom of the tetrazole moiety. 4-Hydroxyvalsartan is only found in individuals that have used or taken Valsartan. These are organic compounds containing a biphenyl attached to a tetrazole.
Structure
Data?1582753148
Synonyms
ValueSource
(2S)-2-(4-Hydroxy-N-{[2'-(2H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}pentanamido)-3-methylbutanoateGenerator
Chemical FormulaC24H29N5O4
Average Molecular Weight451.5182
Monoisotopic Molecular Weight451.221954441
IUPAC Name(2S)-2-[4-hydroxy-N-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]-3-methylbutanoic acid
Traditional Name(2S)-2-[4-hydroxy-N-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]-3-methylbutanoic acid
CAS Registry NumberNot Available
SMILES
CC(O)CCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1)[C@@H](C(C)C)C(O)=O
InChI Identifier
InChI=1S/C24H29N5O4/c1-15(2)22(24(32)33)29(21(31)13-8-16(3)30)14-17-9-11-18(12-10-17)19-6-4-5-7-20(19)23-25-27-28-26-23/h4-7,9-12,15-16,22,30H,8,13-14H2,1-3H3,(H,32,33)(H,25,26,27,28)/t16?,22-/m0/s1
InChI KeyICSQZMPILLPFKC-XLDIYJRPSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as valine and derivatives. Valine and derivatives are compounds containing valine or a derivative thereof resulting from reaction of valine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.
KingdomOrganic compounds
Super ClassOrganic acids and derivatives
ClassCarboxylic acids and derivatives
Sub ClassAmino acids, peptides, and analogues
Direct ParentValine and derivatives
Alternative Parents
Substituents
  • N-acyl-alpha-amino acid
  • Valine or derivatives
  • N-acyl-alpha amino acid or derivatives
  • N-acyl-l-alpha-amino acid
  • Biphenyl
  • Phenyltetrazole
  • Monocyclic benzene moiety
  • N-acyl-amine
  • Benzenoid
  • Azole
  • Heteroaromatic compound
  • Tertiary carboxylic acid amide
  • Tetrazole
  • Secondary alcohol
  • Carboxamide group
  • Monocarboxylic acid or derivatives
  • Carboxylic acid
  • Azacycle
  • Organoheterocyclic compound
  • Organooxygen compound
  • Organonitrogen compound
  • Hydrocarbon derivative
  • Organic oxide
  • Organopnictogen compound
  • Carbonyl group
  • Organic oxygen compound
  • Alcohol
  • Organic nitrogen compound
  • Aromatic heteromonocyclic compound
Molecular FrameworkAromatic heteromonocyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility0.048 g/LALOGPS
logP2.02ALOGPS
logP3.13ChemAxon
logS-4ALOGPS
pKa (Strongest Acidic)3.94ChemAxon
pKa (Strongest Basic)-0.17ChemAxon
Physiological Charge-2ChemAxon
Hydrogen Acceptor Count7ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area132.3 ŲChemAxon
Rotatable Bond Count10ChemAxon
Refractivity136.52 m³·mol⁻¹ChemAxon
Polarizability47.61 ųChemAxon
Number of Rings3ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DarkChem[M+H]+208.56231661259
DarkChem[M-H]-203.08331661259
DeepCCS[M+H]+204.46530932474
DeepCCS[M-H]-202.0730932474
DeepCCS[M-2H]-235.04830932474
DeepCCS[M+Na]+211.38630932474
AllCCS[M+H]+210.932859911
AllCCS[M+H-H2O]+208.832859911
AllCCS[M+NH4]+212.832859911
AllCCS[M+Na]+213.332859911
AllCCS[M-H]-206.132859911
AllCCS[M+Na-2H]-207.132859911
AllCCS[M+HCOO]-208.432859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
4-HydroxyvalsartanCC(O)CCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1)[C@@H](C(C)C)C(O)=O4522.4Standard polar33892256
4-HydroxyvalsartanCC(O)CCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1)[C@@H](C(C)C)C(O)=O3270.9Standard non polar33892256
4-HydroxyvalsartanCC(O)CCC(=O)N(CC1=CC=C(C=C1)C1=CC=CC=C1C1=NN=NN1)[C@@H](C(C)C)C(O)=O3754.0Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
4-Hydroxyvalsartan,1TMS,isomer #1CC(CCC(=O)N(CC1=CC=C(C2=CC=CC=C2C2=NN=N[NH]2)C=C1)[C@H](C(=O)O)C(C)C)O[Si](C)(C)C3673.0Semi standard non polar33892256
4-Hydroxyvalsartan,1TMS,isomer #2CC(O)CCC(=O)N(CC1=CC=C(C2=CC=CC=C2C2=NN=N[NH]2)C=C1)[C@H](C(=O)O[Si](C)(C)C)C(C)C3624.7Semi standard non polar33892256
4-Hydroxyvalsartan,1TMS,isomer #3CC(O)CCC(=O)N(CC1=CC=C(C2=CC=CC=C2C2=NN=NN2[Si](C)(C)C)C=C1)[C@H](C(=O)O)C(C)C3824.3Semi standard non polar33892256
4-Hydroxyvalsartan,2TMS,isomer #1CC(CCC(=O)N(CC1=CC=C(C2=CC=CC=C2C2=NN=N[NH]2)C=C1)[C@H](C(=O)O[Si](C)(C)C)C(C)C)O[Si](C)(C)C3628.4Semi standard non polar33892256
4-Hydroxyvalsartan,2TMS,isomer #2CC(CCC(=O)N(CC1=CC=C(C2=CC=CC=C2C2=NN=NN2[Si](C)(C)C)C=C1)[C@H](C(=O)O)C(C)C)O[Si](C)(C)C3786.7Semi standard non polar33892256
4-Hydroxyvalsartan,2TMS,isomer #3CC(O)CCC(=O)N(CC1=CC=C(C2=CC=CC=C2C2=NN=NN2[Si](C)(C)C)C=C1)[C@H](C(=O)O[Si](C)(C)C)C(C)C3776.0Semi standard non polar33892256
4-Hydroxyvalsartan,3TMS,isomer #1CC(CCC(=O)N(CC1=CC=C(C2=CC=CC=C2C2=NN=NN2[Si](C)(C)C)C=C1)[C@H](C(=O)O[Si](C)(C)C)C(C)C)O[Si](C)(C)C3779.4Semi standard non polar33892256
4-Hydroxyvalsartan,3TMS,isomer #1CC(CCC(=O)N(CC1=CC=C(C2=CC=CC=C2C2=NN=NN2[Si](C)(C)C)C=C1)[C@H](C(=O)O[Si](C)(C)C)C(C)C)O[Si](C)(C)C3614.9Standard non polar33892256
4-Hydroxyvalsartan,3TMS,isomer #1CC(CCC(=O)N(CC1=CC=C(C2=CC=CC=C2C2=NN=NN2[Si](C)(C)C)C=C1)[C@H](C(=O)O[Si](C)(C)C)C(C)C)O[Si](C)(C)C4456.1Standard polar33892256
4-Hydroxyvalsartan,1TBDMS,isomer #1CC(CCC(=O)N(CC1=CC=C(C2=CC=CC=C2C2=NN=N[NH]2)C=C1)[C@H](C(=O)O)C(C)C)O[Si](C)(C)C(C)(C)C3849.6Semi standard non polar33892256
4-Hydroxyvalsartan,1TBDMS,isomer #2CC(O)CCC(=O)N(CC1=CC=C(C2=CC=CC=C2C2=NN=N[NH]2)C=C1)[C@H](C(=O)O[Si](C)(C)C(C)(C)C)C(C)C3834.0Semi standard non polar33892256
4-Hydroxyvalsartan,1TBDMS,isomer #3CC(O)CCC(=O)N(CC1=CC=C(C2=CC=CC=C2C2=NN=NN2[Si](C)(C)C(C)(C)C)C=C1)[C@H](C(=O)O)C(C)C3967.2Semi standard non polar33892256
4-Hydroxyvalsartan,2TBDMS,isomer #1CC(CCC(=O)N(CC1=CC=C(C2=CC=CC=C2C2=NN=N[NH]2)C=C1)[C@H](C(=O)O[Si](C)(C)C(C)(C)C)C(C)C)O[Si](C)(C)C(C)(C)C3942.6Semi standard non polar33892256
4-Hydroxyvalsartan,2TBDMS,isomer #2CC(CCC(=O)N(CC1=CC=C(C2=CC=CC=C2C2=NN=NN2[Si](C)(C)C(C)(C)C)C=C1)[C@H](C(=O)O)C(C)C)O[Si](C)(C)C(C)(C)C4109.9Semi standard non polar33892256
4-Hydroxyvalsartan,2TBDMS,isomer #3CC(O)CCC(=O)N(CC1=CC=C(C2=CC=CC=C2C2=NN=NN2[Si](C)(C)C(C)(C)C)C=C1)[C@H](C(=O)O[Si](C)(C)C(C)(C)C)C(C)C4087.0Semi standard non polar33892256
4-Hydroxyvalsartan,3TBDMS,isomer #1CC(CCC(=O)N(CC1=CC=C(C2=CC=CC=C2C2=NN=NN2[Si](C)(C)C(C)(C)C)C=C1)[C@H](C(=O)O[Si](C)(C)C(C)(C)C)C(C)C)O[Si](C)(C)C(C)(C)C4230.7Semi standard non polar33892256
4-Hydroxyvalsartan,3TBDMS,isomer #1CC(CCC(=O)N(CC1=CC=C(C2=CC=CC=C2C2=NN=NN2[Si](C)(C)C(C)(C)C)C=C1)[C@H](C(=O)O[Si](C)(C)C(C)(C)C)C(C)C)O[Si](C)(C)C(C)(C)C4257.5Standard non polar33892256
4-Hydroxyvalsartan,3TBDMS,isomer #1CC(CCC(=O)N(CC1=CC=C(C2=CC=CC=C2C2=NN=NN2[Si](C)(C)C(C)(C)C)C=C1)[C@H](C(=O)O[Si](C)(C)C(C)(C)C)C(C)C)O[Si](C)(C)C(C)(C)C4530.9Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - 4-Hydroxyvalsartan GC-MS (Non-derivatized) - 70eV, Positivesplash10-000i-4192300000-95389c126057ce193ac52017-09-01Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 4-Hydroxyvalsartan GC-MS (2 TMS) - 70eV, Positivesplash10-00di-9101230000-8a2c579928e8abbfef422017-10-06Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - 4-Hydroxyvalsartan GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 4-Hydroxyvalsartan 10V, Positive-QTOFsplash10-0f8i-0032900000-090a3f00221357e7ad512016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 4-Hydroxyvalsartan 20V, Positive-QTOFsplash10-000i-3198700000-08d3a5c412202f745eca2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 4-Hydroxyvalsartan 40V, Positive-QTOFsplash10-000i-3293000000-6e0d1aa663fbf73da0a42016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 4-Hydroxyvalsartan 10V, Negative-QTOFsplash10-0zfr-0002900000-394299cf885ddb6ab69e2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 4-Hydroxyvalsartan 20V, Negative-QTOFsplash10-0zfr-2219800000-3450a6cb70e11f7ec61b2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 4-Hydroxyvalsartan 40V, Negative-QTOFsplash10-02mj-3916000000-4953d84593a718a96ad32016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 4-Hydroxyvalsartan 10V, Negative-QTOFsplash10-0uea-9000500000-4f74cafb2b4ad511d3522021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 4-Hydroxyvalsartan 20V, Negative-QTOFsplash10-0gc1-4629100000-f7e8f5e1c194841e70f62021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 4-Hydroxyvalsartan 40V, Negative-QTOFsplash10-02t9-5891000000-ecc03346e3445d0088482021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 4-Hydroxyvalsartan 10V, Positive-QTOFsplash10-0f79-0094600000-5c615ff5543c2efc86f02021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 4-Hydroxyvalsartan 20V, Positive-QTOFsplash10-0019-0096000000-326ae10f841aeaa2e2e02021-09-25Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 4-Hydroxyvalsartan 40V, Positive-QTOFsplash10-000i-0191000000-57491a9983bd0556909d2021-09-25Wishart LabView Spectrum
Biological Properties
Cellular Locations
  • Extracellular
Biospecimen Locations
  • Blood
  • Urine
Tissue Locations
  • Kidney
  • Liver
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry details
UrineExpected but not QuantifiedNot QuantifiedNot AvailableNot AvailableTaking drug identified by DrugBank entry details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID8087298
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound9911647
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General ReferencesNot Available

Enzymes

General function:
Involved in monooxygenase activity
Specific function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. This enzyme contributes to the wide pharmacokinetics variability of the metabolism of drugs such as S-warfarin, diclofenac, phenytoin, tolbutamide and losartan.
Gene Name:
CYP2C9
Uniprot ID:
P11712
Molecular weight:
55627.365
References
  1. Zhou SF, Zhou ZW, Yang LP, Cai JP: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675. Epub 2009 Sep 1. [PubMed:19515014 ]
  2. Nakashima A, Kawashita H, Masuda N, Saxer C, Niina M, Nagae Y, Iwasaki K: Identification of cytochrome P450 forms involved in the 4-hydroxylation of valsartan, a potent and specific angiotensin II receptor antagonist, in human liver microsomes. Xenobiotica. 2005 Jun;35(6):589-602. [PubMed:16192110 ]
  3. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
General function:
Involved in G-protein coupled receptor protein signaling pathway
Specific function:
Receptor for angiotensin II. Mediates its action by association with G proteins that activate a phosphatidylinositol- calcium second messenger system
Gene Name:
AGTR1
Uniprot ID:
P30556
Molecular weight:
41060.5
References
  1. Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. [PubMed:11752352 ]
  2. Azizi M, Menard J, Bissery A, Guyenne TT, Bura-Riviere A, Vaidyanathan S, Camisasca RP: Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption. J Am Soc Nephrol. 2004 Dec;15(12):3126-33. [PubMed:15579516 ]
  3. Criscione L, de Gasparo M, Buhlmayer P, Whitebread S, Ramjoue HP, Wood J: Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype. Br J Pharmacol. 1993 Oct;110(2):761-71. [PubMed:8242249 ]
  4. Shargorodsky M, Leibovitz E, Lubimov L, Gavish D, Zimlichman R: Prolonged treatment with the AT1 receptor blocker, valsartan, increases small and large artery compliance in uncomplicated essential hypertension. Am J Hypertens. 2002 Dec;15(12):1087-91. [PubMed:12460705 ]
  5. de Gasparo M, Whitebread S: Binding of valsartan to mammalian angiotensin AT1 receptors. Regul Pept. 1995 Nov 10;59(3):303-11. [PubMed:8577935 ]
  6. Siragy HM, El-Kersh MA, De Gasparo M, Webb RL, Carey RM: Differences in AT2 -receptor stimulation between AT1 -receptor blockers valsartan and losartan quantified by renal interstitial fluid cGMP. J Hypertens. 2002 Jun;20(6):1157-63. [PubMed:12023686 ]

Transporters

General function:
Involved in transporter activity
Specific function:
Mediates the Na(+)-independent transport of organic anions such as 17-beta-glucuronosyl estradiol, taurocholate, triiodothyronine (T3), leukotriene C4, dehydroepiandrosterone sulfate (DHEAS), methotrexate and sulfobromophthalein (BSP)
Gene Name:
SLCO1B3
Uniprot ID:
Q9NPD5
Molecular weight:
77402.2
References
  1. Poirier A, Cascais AC, Funk C, Lave T: Prediction of pharmacokinetic profile of valsartan in human based on in vitro uptake transport data. J Pharmacokinet Pharmacodyn. 2009 Dec;36(6):585-611. doi: 10.1007/s10928-009-9139-3. Epub 2009 Nov 20. [PubMed:19936896 ]
  2. Poirier A, Cascais AC, Funk C, Lave T: Prediction of pharmacokinetic profile of valsartan in humans based on in vitro uptake-transport data. Chem Biodivers. 2009 Nov;6(11):1975-87. doi: 10.1002/cbdv.200900116. [PubMed:19937834 ]
General function:
Involved in transporter activity
Specific function:
Mediates the Na(+)-independent transport of organic anions such as pravastatin, taurocholate, methotrexate, dehydroepiandrosterone sulfate, 17-beta-glucuronosyl estradiol, estrone sulfate, prostaglandin E2, thromboxane B2, leukotriene C3, leukotriene E4, thyroxine and triiodothyronine. May play an important role in the clearance of bile acids and organic anions from the liver
Gene Name:
SLCO1B1
Uniprot ID:
Q9Y6L6
Molecular weight:
76448.0
References
  1. Poirier A, Cascais AC, Funk C, Lave T: Prediction of pharmacokinetic profile of valsartan in human based on in vitro uptake transport data. J Pharmacokinet Pharmacodyn. 2009 Dec;36(6):585-611. doi: 10.1007/s10928-009-9139-3. Epub 2009 Nov 20. [PubMed:19936896 ]
  2. Poirier A, Cascais AC, Funk C, Lave T: Prediction of pharmacokinetic profile of valsartan in humans based on in vitro uptake-transport data. Chem Biodivers. 2009 Nov;6(11):1975-87. doi: 10.1002/cbdv.200900116. [PubMed:19937834 ]